NTC concludes probe: Anti-dumping duties imposed on Cefadroxil imports

ISLAMABAD: The National Tariff Commission (NTC) has imposed definitive anti-dumping duties on dumped imports of Cefadroxil into Pakistan originating in and/ or exported from China. The Commission initiated this anti-dumping investigation on May 21, 2025. The final determination is based on the information collected and/or obtained by the Commission during the investigation.

According to NTC, the individual dumping margin has been determined based on information submitted by M/s Anglikang. A residual dumping margin for all the non-cooperating exporters/producers from China is determined on the basis of best available information in terms of Section 32 of the Act.

For the purpose of imposition of lesser duty in terms of Section 50 (2) of the Act the Commission has calculated injury margins in accordance with Rule 21 of the Rules to ascertain whether a lower duty would be adequate to remove injury being suffered by the domestic industry due to dumped imports of investigated product.

Calculations of injury margin are as follows: (i) cost to make and sell of the domestic like product (Rs/kg) 100.00; (ii) profit: 5 percent of cost to make and sell 5.00; (iii) estimated Non-injurious price of the domestic like product (Rs/kg) 105.00; (iv) C&F price of investigated product (Rs/kg) 78.30; (v) landed cost of investigated product (Rs/ kg) 84.94; (vi) absolute injury margin (Rs/kg) 20.06; and (vii) Injury Margin as % of C&F Price 25.61.

The NTC argued that the injury margin worked out at 25.61 percent, which is above the dumping margin determined for the M/s Anglikang and non-cooperating exporters/producers from China. Thus, in terms of Section 50 (2) of the Act, lesser duty would be adequate to remove injury to the domestic industry. Therefore, the Commission, pursuant to powers under Section 50 of the Act, decided to impose definitive anti-dumping duties at the rates on C&F value in ad valorem terms on imports of the investigated product imported from China for a period of five years effective from September 17, 2025. However, in accordance with Section 51(ea) of the Act, definitive anti-dumping duty will not be levied on imports of the investigated product that are used as inputs in products destined solely for exports or for use in the foreign grant-in-aid projects and are covered under any scheme exempting customs duties for exports or foreign grant-in-aid projects under the Customs Act, 1969 (IV of 1969).

The investigated product is classified under PCT heading No. 2941.9090.

Definitive anti-dumping duty rates are as follows: (i) M/s Zhejiang Anglikang Pharmaceuticals 8.61 percent; and (ii) all other exporters/foreign producers 11.81 percent.

The investigated product imported from sources other than China shall not be subject to the above-mentioned definitive anti-dumping duties.

Furthermore, as the definitive anti-dumping duty rates for all exporters/foreign producers from China are lower as compared to provisional duty rates claims for refund of difference between provisional anti-dumping duty and final anti-dumping duty with respect to the import of the investigated product would be entertained, if claimed, within the stipulated time period under Section 55(2) of the Act.

In accordance with Section 51 of the Act, the definitive anti-dumping duties shall take the form of ad valorem duty and be held in a non-lapsable personal ledger account established and maintained by the Commission for this purpose.

The release of the investigated product shall be subject to imposition of such anti-dumping duty.

Definitive anti-dumping duties levied would be in addition to other taxes and duties leviable on import of the investigated product under any other law.

The definitive anti-dumping duties would be collected in the same manner as Customs duty is collected under the Customs Act, 1969 (IV of 1969) and would be deposited in Commission’s Non-Lapsable PLD Account.

Copyright Business Recorder, 2026